Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

A preclinical large-animal model for the assessment of critical-size load-bearing bone defect reconstruction.

Sparks DS, Saifzadeh S, Savi FM, Dlaska CE, Berner A, Henkel J, Reichert JC, Wullschleger M, Ren J, Cipitria A, McGovern JA, Steck R, Wagels M, Woodruff MA, Schuetz MA, Hutmacher DW.

Nat Protoc. 2020 Feb 14. doi: 10.1038/s41596-019-0271-2. [Epub ahead of print]

PMID:
32060491
2.

The Effect of Intravenous Acetaminophen on Patient Outcomes within a Large Integrated Delivery Network.

Mattern HP, Reichert JC, McConnell KJ.

Pharmacotherapy. 2020 Jan 28. doi: 10.1002/phar.2372. [Epub ahead of print]

PMID:
31994206
3.

[Fast track strategies in hip arthroplasty].

Nöth U, Geiser T, Kranich T, von Rottkay E, Reichert JC, Reyle-Hahn M, Rackwitz L.

Orthopade. 2019 Apr;48(4):330-336. doi: 10.1007/s00132-019-03697-7. Review. German.

PMID:
30758539
4.

[Cell-based and future therapeutic strategies for femoral head necrosis].

Rackwitz L, Reichert JC, Haversath M, Nöth U, Jäger M.

Orthopade. 2018 Sep;47(9):770-776. doi: 10.1007/s00132-018-3619-3. Review. German.

PMID:
30143825
5.

A prospective randomized comparison of the minimally invasive direct anterior and the transgluteal approach for primary total hip arthroplasty.

Reichert JC, von Rottkay E, Roth F, Renz T, Hausmann J, Kranz J, Rackwitz L, Nöth U, Rudert M.

BMC Musculoskelet Disord. 2018 Jul 19;19(1):241. doi: 10.1186/s12891-018-2133-4.

6.

[New experimental strategies in cartilage surgery].

Rackwitz L, Reichert JC, Pullig O, Nöth U.

Orthopade. 2017 Nov;46(11):947-953. doi: 10.1007/s00132-017-3479-2. Review. German.

PMID:
28993845
7.

Necrotizing streptococcal myositis of the upper extremity: a case report.

Reichert JC, Habild G, Simon P, Nöth U, Krümpelmann JB.

BMC Res Notes. 2017 Aug 15;10(1):407. doi: 10.1186/s13104-017-2743-1.

8.

A humanised tissue-engineered bone model allows species-specific breast cancer-related bone metastasis in vivo.

Quent V, Taubenberger AV, Reichert JC, Martine LC, Clements JA, Hutmacher DW, Loessner D.

J Tissue Eng Regen Med. 2018 Feb;12(2):494-504. doi: 10.1002/term.2517. Epub 2017 Nov 29.

PMID:
28714574
9.

Function and activity after minimally invasive total hip arthroplasty compared to a healthy population.

von Rottkay E, Rackwitz L, Rudert M, Nöth U, Reichert JC.

Int Orthop. 2018 Feb;42(2):297-302. doi: 10.1007/s00264-017-3541-z. Epub 2017 Jul 12.

PMID:
28702750
10.

[Patellar tendon injuries after total knee arthroplasty : Classification and management].

Nöth U, Trojanowski M, Reichert JC, Rolf O, Rackwitz L.

Orthopade. 2016 May;45(5):425-32. doi: 10.1007/s00132-016-3257-6. Review. German.

PMID:
27125234
11.

Poly(ε-caprolactone) Scaffolds Fabricated by Melt Electrospinning for Bone Tissue Engineering.

Zaiss S, Brown TD, Reichert JC, Berner A.

Materials (Basel). 2016 Mar 25;9(4). pii: E232. doi: 10.3390/ma9040232.

12.

Scaffold-cell bone engineering in a validated preclinical animal model: precursors vs differentiated cell source.

Berner A, Henkel J, Woodruff MA, Saifzadeh S, Kirby G, Zaiss S, Gohlke J, Reichert JC, Nerlich M, Schuetz MA, Hutmacher DW.

J Tissue Eng Regen Med. 2017 Jul;11(7):2081-2089. doi: 10.1002/term.2104. Epub 2015 Dec 9.

PMID:
26648044
13.

BMP delivery complements the guiding effect of scaffold architecture without altering bone microstructure in critical-sized long bone defects: A multiscale analysis.

Cipitria A, Wagermaier W, Zaslansky P, Schell H, Reichert JC, Fratzl P, Hutmacher DW, Duda GN.

Acta Biomater. 2015 Sep;23:282-294. doi: 10.1016/j.actbio.2015.05.015. Epub 2015 May 22.

PMID:
26004222
14.

Comparative retrospective study of the direct anterior and transgluteal approaches for primary total hip arthroplasty.

Reichert JC, Volkmann MR, Koppmair M, Rackwitz L, Lüdemann M, Rudert M, Nöth U.

Int Orthop. 2015 Dec;39(12):2309-13. doi: 10.1007/s00264-015-2732-8. Epub 2015 Mar 21.

PMID:
25795247
15.

Differential osteogenicity of multiple donor-derived human mesenchymal stem cells and osteoblasts in monolayer, scaffold-based 3D culture and in vivo.

Quent VM, Theodoropoulos C, Hutmacher DW, Reichert JC.

Biomed Tech (Berl). 2016 Jun 1;61(3):253-66. doi: 10.1515/bmt-2014-0159.

16.

Chondrogenic predifferentiation of human mesenchymal stem cells in collagen type I hydrogels.

Fensky F, Reichert JC, Traube A, Rackwitz L, Siebenlist S, Nöth U.

Biomed Tech (Berl). 2014 Oct;59(5):375-83. doi: 10.1515/bmt-2013-0076.

PMID:
24803605
17.

Polycaprolactone scaffold and reduced rhBMP-7 dose for the regeneration of critical-sized defects in sheep tibiae.

Cipitria A, Reichert JC, Epari DR, Saifzadeh S, Berner A, Schell H, Mehta M, Schuetz MA, Duda GN, Hutmacher DW.

Biomaterials. 2013 Dec;34(38):9960-8. doi: 10.1016/j.biomaterials.2013.09.011. Epub 2013 Sep 24.

PMID:
24075478
18.

Synergistic effect of Indian hedgehog and bone morphogenetic protein-2 gene transfer to increase the osteogenic potential of human mesenchymal stem cells.

Reichert JC, Schmalzl J, Prager P, Gilbert F, Quent VM, Steinert AF, Rudert M, Nöth U.

Stem Cell Res Ther. 2013;4(5):105.

19.

Mesodermal and neural crest derived ovine tibial and mandibular osteoblasts display distinct molecular differences.

Reichert JC, Gohlke J, Friis TE, Quent VM, Hutmacher DW.

Gene. 2013 Aug 1;525(1):99-106. doi: 10.1016/j.gene.2013.04.026. Epub 2013 Apr 28.

PMID:
23632238
20.

Autologous vs. allogenic mesenchymal progenitor cells for the reconstruction of critical sized segmental tibial bone defects in aged sheep.

Berner A, Reichert JC, Woodruff MA, Saifzadeh S, Morris AJ, Epari DR, Nerlich M, Schuetz MA, Hutmacher DW.

Acta Biomater. 2013 Aug;9(8):7874-84. doi: 10.1016/j.actbio.2013.04.035. Epub 2013 Apr 27.

PMID:
23628773
21.

How smart do biomaterials need to be? A translational science and clinical point of view.

Holzapfel BM, Reichert JC, Schantz JT, Gbureck U, Rackwitz L, Nöth U, Jakob F, Rudert M, Groll J, Hutmacher DW.

Adv Drug Deliv Rev. 2013 Apr;65(4):581-603. doi: 10.1016/j.addr.2012.07.009. Epub 2012 Jul 20. Review.

PMID:
22820527
22.

A tissue engineering solution for segmental defect regeneration in load-bearing long bones.

Reichert JC, Cipitria A, Epari DR, Saifzadeh S, Krishnakanth P, Berner A, Woodruff MA, Schell H, Mehta M, Schuetz MA, Duda GN, Hutmacher DW.

Sci Transl Med. 2012 Jul 4;4(141):141ra93. doi: 10.1126/scitranslmed.3003720.

23.

[Bone tissue engineering. Reconstruction of critical sized segmental bone defects in the ovine tibia].

Reichert JC, Epari DR, Wullschleger ME, Berner A, Saifzadeh S, Nöth U, Dickinson IC, Schuetz MA, Hutmacher DW.

Orthopade. 2012 Apr;41(4):280-7. doi: 10.1007/s00132-011-1855-x. German.

PMID:
22476418
24.

[Reconstruction of osteochondral defects with a collagen I hydrogel. Results of a prospective multicenter study].

Rackwitz L, Schneider U, Andereya S, Siebenlist S, Reichert JC, Fensky F, Arnholdt J, Löer I, Grossstück R, Zinser W, Barthel T, Rudert M, Nöth U.

Orthopade. 2012 Apr;41(4):268-79. doi: 10.1007/s00132-011-1853-z. German. Erratum in: Orthopade. 2012 May;41(5):412. Arnhold, J [corrected to Arnholdt, J].

PMID:
22476417
25.

Porous scaffold architecture guides tissue formation.

Cipitria A, Lange C, Schell H, Wagermaier W, Reichert JC, Hutmacher DW, Fratzl P, Duda GN.

J Bone Miner Res. 2012 Jun;27(6):1275-88. doi: 10.1002/jbmr.1589.

26.

Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head.

Rackwitz L, Eden L, Reppenhagen S, Reichert JC, Jakob F, Walles H, Pullig O, Tuan RS, Rudert M, Nöth U.

Stem Cell Res Ther. 2012 Feb 22;3(1):7. doi: 10.1186/scrt98. Review.

27.

Biphasic bone substitute and fibrin sealant for treatment of benign bone tumours and tumour-like lesions.

Reppenhagen S, Reichert JC, Rackwitz L, Rudert M, Raab P, Daculsi G, Nöth U.

Int Orthop. 2012 Jan;36(1):139-48. doi: 10.1007/s00264-011-1282-y. Epub 2011 May 28.

28.

Treatment of long bone defects and non-unions: from research to clinical practice.

Berner A, Reichert JC, Müller MB, Zellner J, Pfeifer C, Dienstknecht T, Nerlich M, Sommerville S, Dickinson IC, Schütz MA, Füchtmeier B.

Cell Tissue Res. 2012 Mar;347(3):501-19. doi: 10.1007/s00441-011-1184-8. Epub 2011 May 17. Review.

PMID:
21574059
29.

Ovine cortical osteoblasts outperform bone marrow cells in an ectopic bone assay.

Reichert JC, Quent VM, Nöth U, Hutmacher DW.

J Tissue Eng Regen Med. 2011 Nov;5(10):831-44. doi: 10.1002/term.392. Epub 2011 Feb 10.

PMID:
21312337
30.

Custom-made composite scaffolds for segmental defect repair in long bones.

Reichert JC, Wullschleger ME, Cipitria A, Lienau J, Cheng TK, Schütz MA, Duda GN, Nöth U, Eulert J, Hutmacher DW.

Int Orthop. 2011 Aug;35(8):1229-36. doi: 10.1007/s00264-010-1146-x. Epub 2010 Dec 7.

31.

Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment.

Reichert JC, Quent VM, Burke LJ, Stansfield SH, Clements JA, Hutmacher DW.

Biomaterials. 2010 Nov;31(31):7928-36. doi: 10.1016/j.biomaterials.2010.06.055. Epub 2010 Aug 5.

PMID:
20688384
32.

Ovine bone- and marrow-derived progenitor cells and their potential for scaffold-based bone tissue engineering applications in vitro and in vivo.

Reichert JC, Woodruff MA, Friis T, Quent VM, Gronthos S, Duda GN, Schütz MA, Hutmacher DW.

J Tissue Eng Regen Med. 2010 Oct;4(7):565-76. doi: 10.1002/term.276.

PMID:
20568083
33.

[Reconstruction of osteochondral defects with a stem cell-based cartilage-polymer construct in a small animal model].

Berner A, Siebenlist S, Reichert JC, Hendrich C, Nöth U.

Z Orthop Unfall. 2010 Jan;148(1):31-8. doi: 10.1055/s-0029-1240753. Epub 2010 Feb 11. German.

PMID:
20151353
34.

Discrepancies between metabolic activity and DNA content as tool to assess cell proliferation in cancer research.

Quent VM, Loessner D, Friis T, Reichert JC, Hutmacher DW.

J Cell Mol Med. 2010 Apr;14(4):1003-13. doi: 10.1111/j.1582-4934.2010.01013.x. Epub 2010 Jan 15.

35.

Fabrication of polycaprolactone collagen hydrogel constructs seeded with mesenchymal stem cells for bone regeneration.

Reichert JC, Heymer A, Berner A, Eulert J, Nöth U.

Biomed Mater. 2009 Dec;4(6):065001. doi: 10.1088/1748-6041/4/6/065001.

PMID:
19837997
36.

Establishment of a preclinical ovine model for tibial segmental bone defect repair by applying bone tissue engineering strategies.

Reichert JC, Epari DR, Wullschleger ME, Saifzadeh S, Steck R, Lienau J, Sommerville S, Dickinson IC, Schütz MA, Duda GN, Hutmacher DW.

Tissue Eng Part B Rev. 2010 Feb;16(1):93-104. doi: 10.1089/ten.TEB.2009.0455.

PMID:
19795978
37.

Strategies for zonal cartilage repair using hydrogels.

Klein TJ, Rizzi SC, Reichert JC, Georgi N, Malda J, Schuurman W, Crawford RW, Hutmacher DW.

Macromol Biosci. 2009 Nov 10;9(11):1049-58. doi: 10.1002/mabi.200900176.

PMID:
19739068
38.

Translating tissue engineering technology platforms into cancer research.

Hutmacher DW, Horch RE, Loessner D, Rizzi S, Sieh S, Reichert JC, Clements JA, Beier JP, Arkudas A, Bleiziffer O, Kneser U.

J Cell Mol Med. 2009 Aug;13(8A):1417-27. doi: 10.1111/j.1582-4934.2009.00853.x. Epub 2009 Jul 20. Review.

39.

The challenge of establishing preclinical models for segmental bone defect research.

Reichert JC, Saifzadeh S, Wullschleger ME, Epari DR, Schütz MA, Duda GN, Schell H, van Griensven M, Redl H, Hutmacher DW.

Biomaterials. 2009 Apr;30(12):2149-63. doi: 10.1016/j.biomaterials.2008.12.050. Epub 2009 Feb 10. Review.

PMID:
19211141
40.

Using LOINC to link an EMR to the pertinent paragraph in a structured reference knowledge base.

Reichert JC, Glasgow M, Narus SP, Clayton PD.

Proc AMIA Symp. 2002:652-6.

Supplemental Content

Loading ...
Support Center